Joel Lilly
Joel D. Lilly, M.D.

Joel D. Lilly, M.D.

Joel D. Lilly, M.D.
Specialty

Robotic Surgery, Urology, Surgery

Clinical Interests / Special Procedures Performed

Biliary & Kidney Stents, Bladder Cancer, Bladder Tumors, Bloodless Surgery, Brachytherapy Seed Implant, Cancer Screening, Cancer Surgery, Circumcision, Clinical Research & Educ., Clinical Trials, da Vinci (Robot-Assisted Surgery), Endourology, Erectile Dysfunction, Evidence-Based Health Care, Genital Warts, Genitourinary Cancers, HDR Implants, High Dose Rate Brachytherapy, Implants, Impotence, Incontinence, Kidney Cancer, Kidney Stones (Lithotripsy), Laparoscopic Surgery, Laparoscopy, Laser Surgery, Laser Therapy, Lithotripsy, Men's Issues, Minimally Invasive Procedures, Nephrolithinsis, Office Surgery & Procedures, Oncologic Surgery, Permanent Seed Implants, Prostate Cancer, Prostate Disease/Ultrasound, Prostate Surgery, Prostate/BPH Treatment, Prostatectomy (Robotic), Prostatic Obstruction, Radiofrequency Ablation, Renal Cell Cancer, Renal stones, Seed Implantation - Prostate, Sexual Difficulties, Sexual Dysfunction - Male, Shock Wave Therapy, Stenting, Stone Disease, Surgery, Testicle Cancer, Ultrasound, Ultrasound-Guided Biopsy, Urinary Incontinence, Urinary Stone Disease, Urinary Tract Infections, Urologic Laparoscopic Surgery, Urologic Oncology, Urology, Vasectomy, Vasectomy - No scalpel

  • Accepting Children: No
  • Accepting New Patients: Yes
  • Accepting Medicare: Yes
  • Accepting Medicaid/DSHS: No
Payment Methods Accepted:

Medicare, Bill Insurance, VISA, Master Card, Cash, Check, Payment Plan, American Express

Insurance Accepted:

Contact this office for accepted insurance plans.

Additional Information:

Swedish Medical Center - Past Chief of Urology, Medical Director, Genitourinary Oncology; Other: Washington State Urology Society - Past President

Philosophy of Care

I make every effort to treat each patient with respect; to give each patient the type of care I would want for my own family. I balance the latest advancements in technology with personality. When my patients need surgery, I enjoy giving them the best possible outcomes, mixed with a "bedside manner" they will want to tell their friends about.

Personal Interests

I have two fantastic kids. My daughter is a star basketball player at Emory University and my son is an aspiring guitarist.. My parents recently moved to Issaquah from the east coast. I spend a lot of time with my family, whether it is being the team photographer for my kids' basketball teams or just helping with homework. I love to ski, hike and play tennis here in the northwest. My favorite hobby is photography, especially of my kids in sports.

Medical School

University of North Carolina, NC

Residency

University of California at San Diego, CA

Board Certifications

American Board of Urology

Additional Information:

Swedish Medical Center - Past Chief of Urology, Medical Director, Genitourinary Oncology; Other: Washington State Urology Society - Past President

Why "Movember" means talking about prostate cancer

It is now the beginning of November, marked by colorful foliage, leftover candy and thoughts of the upcoming holidays. It will also be the first of Movember, the last day to cleanly shave that upper lip for a month. The rest of the month we are to let the mustaches emerge and flourish as a reminder of prostate cancer in the community. 

The Movember movement began ...

Prostate Cancer Screening

This week a large European consortium updated the data on a huge study on prostate cancer screening. The study included over 160,000 men in eight European countries followed for an average of 11 years. The men were randomly assigned to prostate cancer screening with the PSA blood test or no screening. The primary endpoint of the study was death from prostate cancer. The current report in the New England Journal of Medicine gave an additional two years of follow-up data over the prior reports.

As expected with longer follow-up, the benefits from screening have become more clear. The study now shows a 29% decrease in the number of men dying from prostate cancer in the screened group. This confirms the expected benefit for early detection.

This publication comes at a time of great controversy regarding prostate cancer screening here in the United States...

PCA3 - New help in diagnosing prostate cancer

This month the FDA approved the use of the PCA3 assay to aid in the diagnosis of prostate cancer. This is good news for patients with an elevated PSA (prostate specific antigen) blood test who are concerned about their risk of having prostate cancer. The PCA3 test is used on urine samples from men after a prostate exam has been performed. It measures the number of copies of a prostate cancer related gene, and compares it to the number of copies of the gene for PSA. Studies have shown that the use of this assay can help sort out who is at higher risk for prostate cancer. This can help patients and urologists decide who would likely benefit from a prostate biopsy.

The FDA specifically approved the PCA3 assay for men who ...

Results 1-3 of 3
  • 1

Offices

Seattle Urological Associates, a division of Minor & James Medical
1221 Madison St.
Suite 1210
Seattle, WA 98104
Phone: (206) 215-2580
Fax: (206) 215-2581
Monday
8:00 AM to 5:00 PM
Tuesday
8:00 AM to 5:00 PM
Wednesday
8:00 AM to 5:00 PM

Thursday
8:00 AM to 5:00 PM
Friday
8:00 AM to 5:00 PM

Map & Directions

Physicians: Is this your profile? Click here for info